Rajiv Patni, Chief Development Officer at Ocera Therapeutics, Inc. (OCRX), bought 5,050 shares at $3.97 ($20K) on 2015-05-07, disclosed to the SEC on 2015-05-07.
Open-market purchase of $20k OCRX by Chief Development Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ADMS | SELL | 2017-03-22 | $12K | — | Filing → |